Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX Pancreas Vaccine With or Without Cyclophosphamide in Surgically Resected Pancreatic Cancer
NCT01088789Phase 2Active, not recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Apr 2010
- Primary completion
- Jul 2024
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GVAX pancreatic cancer vaccine in pancreatic adenocarcinoma (PDAC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Apr 2010; status: active, not recruiting.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01088789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088789.